Archive: 16/05/2014

Tailored intervention does not up CRC screening rates

(HealthDay)—An interactive multimedia computer program (IMCP) tailored to expanded health belief model sociopsychological factors is no more effective for encouraging colorectal cancer screening than a control nontailored ...

May 16, 2014

0

0

Noninvasive first-trimester screen drops CVS/amnio rates

(HealthDay)—The introduction of combined first-trimester screening correlated with an increase in chorionic villus sampling (CVS) and a decrease in amniocentesis, while both CVS and amniocentesis decreased with the introduction ...

May 16, 2014

0

0

ASH: Accurate HTN information available on YouTube

(HealthDay)—Many of the hypertension-related videos available on YouTube are useful, but these tend to be viewed and "liked" less, and home blood pressure (BP) devices for the iPhone seem not to be reliable. These findings ...

May 16, 2014

0

0

Non-invasive lithotripsy leads to more treatment for kidney stones

When it comes to treating kidney stones, less invasive may not always be better, according to new research from Duke Medicine.

May 16, 2014

Post-spinal surgery ultrasound aids VTE management

(HealthDay)—Perioperative ultrasonography is important for proper management of venous thromboembolism (VTE), according to a study published in the May 1 issue of Spine.

May 16, 2014

0

0

People with high blood pressure often have a 'salt tooth'

(HealthDay)—High salt intake is a known risk factor for high blood pressure and stroke, so experts say it's concerning that a new study finds people with high blood pressure tend to prefer saltier foods.

May 16, 2014

0

1

Using internet, apps to manage blood pressure has dangers, study says

(HealthDay)—People who turn to the Internet or iPhone apps for help in controlling their blood pressure may be led astray in some cases, two preliminary studies suggest.

May 16, 2014

0

0

Pfizer seeks early approval for breast cancer drug

Pfizer Inc. says the Food and Drug Administration will let the drugmaker apply for approval of its heavily touted experimental breast cancer medicine based on midstage patient testing results.

May 16, 2014

Ataluren Phase 3 trial results in nonsense mutation cystic fibrosis

PTC Therapeutics, Inc. today announced that the results of a Phase 3 study of ataluren in patients with nonsense mutation cystic fibrosis (nmCF) were published in Lancet Respiratory Medicine. The results demonstrated positive ...

May 16, 2014

Herpes-loaded stem cells used to kill brain tumors

(Medical Xpress)—Harvard Stem Cell Institute (HSCI) scientists at Massachusetts General Hospital have a potential solution for how to more effectively kill tumor cells using cancer-killing viruses. The investigators report ...

May 16, 2014

0

0

page 2 from 6

Archive: 16/05/2014

Tailored intervention does not up CRC screening rates

Noninvasive first-trimester screen drops CVS/amnio rates

ASH: Accurate HTN information available on YouTube

Non-invasive lithotripsy leads to more treatment for kidney stones

Post-spinal surgery ultrasound aids VTE management

People with high blood pressure often have a 'salt tooth'

Using internet, apps to manage blood pressure has dangers, study says

Pfizer seeks early approval for breast cancer drug

Ataluren Phase 3 trial results in nonsense mutation cystic fibrosis

Herpes-loaded stem cells used to kill brain tumors

Phys.org

Tech Xplore

Science X